Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18755InvestigationalSmall molecule
Monepantel: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Serine/threonine-protein kinase mTOR, Acetylcholine receptor subunit alpha-type unc-38, and Acetylcholine receptor subunit alpha-type unc-63
- Formula / weight
- C20H13F6N3O2S · 473.39 g/mol (avg)
- Also known as
- Benzamide, n-((1s)-1-cyano-2-(5-cyano-2-(trifluoromethyl)phenoxy)-1-methylethyl)-4-((trifluoromethyl)thio)- · Monepantel component of zolvix · N-(2-cyano-1-((2s)-5-cyano-2-(trifluoromethyl)phenoxy)propan-2-yl)-4-(trifluoromethylsulfanyl)benzamide · Zolvix component monepantel
Resolves to
Structure
InChIKey
WTERNLDOAPYGJD-SFHVURJKSA-NSMILESC[C@](COC1=CC(=CC=C1C(F)(F)F)C#N)(NC(=O)C1=CC=C(SC(F)(F)F)C=C1)C#NTransporters
What you can answer from here — as of July 09, 2026
5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Monepantel, and which of those have an active Phase 3 trial?